Southern Star Research
Robert Kent is a Senior Director of Business Development at Southern Star Research, where Robert helps Biopharmaceutical and Medical Device companies optimize their clinical trials in Australia and the Asia-Pac region. With a background in nursing from Wolfson School of Nursing, Robert has held various high-level business development roles in companies such as AliveCor Inc., Premier Research, Spaulding Clinical, and Quintiles, specializing in cardiac safety services. Prior to their career in business development, Robert worked as a Registered Nurse and Charge Nurse in the CCU at Chelsea and Westminster Hospital NHS Foundation Trust.
This person is not in any teams
This person is not in any offices
Southern Star Research
Sydney-based CRO Southern Star Research can access the financial, operational and regulatory advantages of conducting clinical trials in Australia. This local knowledge, as well as our full-service offering, enables our biotechnology, pharmaceutical and medical device customers to benefit from the Australian environment. We have expertise in a broad range of indications, and a Clinical Team who have an average of 17 years direct clinical research experience. Furthermore, all of our work is underpinned by a passion for cutting edge science, a keen interest in early stage clinical development and a willingness to provide every client with exceptional customer service. With a track record of success in clinical trials spanning Phase I to IV, Southern Star Research has both the capability and the drive to support your R&D objectives in Australia and Asia-Pacific.